National Medical Research Radiological Center

What National Medical Research Radiological Center does

The National Medical Research Radiological Center (NMRRC) is a Federal State Budgetary Institution under the Ministry of Health of the Russian Federation, established in 2014 by consolidating three historic research institutes: the P. Hertsen Moscow Oncology Research Institute (founded 1898), the A. Tsyb Medical Radiological Research Center in Obninsk, and the N. Lopatkin Scientific Research Institute of Urology and Interventional Radiology. Headquartered in Moscow with a secondary branch in Obninsk (Kaluga Oblast), it operates approximately 3,500 staff across three sites and serves over 100,000 patients annually. The center has been granted state honors including the Order of Pirogov and the Order of the Red Banner of Labor, and is designated as the Federal Reference Center for pathomorphological, molecular-genetic, and radiation research methods, as well as the base oncological institution of the CIS countries. General Director Andrey Kaprin (Academician of the Russian Academy of Sciences, Chief Oncologist of Russia) leads the institution.

The center delivers a comprehensive multi-modal oncology, urology, and radiology service portfolio spanning diagnostics through survivorship. Core capabilities include PET/CT, MRI, CT and ultrasound diagnostics; advanced radiation and proton therapy; bone marrow and hematopoietic stem cell transplantation; radioembolization using domestically produced microspheres; brachytherapy using domestic iodine-125 sources; CAR-T cell therapy; pressurized intraperitoneal aerosol chemotherapy (PIPAC); da Vinci robotic surgery; molecular-genetic, immunohistochemical, and cytogenetic testing at scale (~3.5 million clinical diagnostic tests per year); reconstructive and plastic surgery (~2,100 procedures annually); fertility preservation via the CryoBank program; and a preventive screening initiative called Oncopatrul. The facility also operates a reference center for verification of morphological and microbiological research, a telemedicine consultation service, and educational pipelines through ordinatura, aspirantura, and continuing medical education programs.

NMRRC's revenue model is anchored in state funding via compulsory medical insurance (OMS) and federal high-tech medical aid (VMP) budget allocations, supplemented by fee-for-service paid medical services and a dedicated international medical tourism program serving CIS, Chinese, and Middle Eastern patients. Customer acquisition occurs through three branch-level call centers, a unified hotline (8-800-444-31-02), online appointment booking, and a multilingual website. As a state institution, revenue is not publicly disclosed; financial scale is best inferred from headcount, throughput, and the capital-intensive modalities operated (proton therapy, CAR-T manufacturing, robotic surgery). Strategic positioning is built on regulatory mandate, accumulated specialist talent, integrated multi-branch patient routing, and the rare combination of domestic-source advanced radiotherapy inputs.

Name

National Medical Research Radiological Center

Legal name

ФГБУ «НМИЦ радиологии» Минздрава России (Federal State Budgetary Institution National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation)

Website

https://new.nmicr.ru

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Federal Russian medical research center consolidating three historic institutes to deliver multi-modal oncology, urology, and radiology care, employing 3,500 staff across three branches and serving 100,000+ patients annually under the Ministry of Health.

Ownership category

akta.pro rank

Product category

Specialty Oncology and Radiology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Diagnostic Imaging Centers (621512), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Radiation Oncology (HLAKAFAC), Medical Oncology (HLAKAFAB), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI), Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB), Urologic Oncology (HLAKAOAB)

Keywords

• Oncology diagnostics
• Radiation therapy services
• Urology treatment
• Interventional radiology
• Specialty cancer hospital

Headquarters

HQ city

Moscow

HQ country

Russia

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

1. State Guaranteed Medical Care (OMS): The center provides medical services under the state program of guaranteed free medical care for citizens funded through compulsory medical insurance (OMS). This is the primary revenue stream for the majority of Russian Federation citizens.
2. High-Tech Medical Aid (VMP): Specialized and high-technology medical care funded through federal budget allocations, provided beyond standard OMS volumes.
3. Fee-for-Service Paid Medical Services: Paid medical services provided at the expense of citizens' personal funds, employers' funds, or voluntary health insurance. Services include those outside the state guarantee program, anonymous services, and care for foreign nationals.
4. International Medical Tourism: Medical services provided to foreign nationals and international patients, as a separate revenue stream.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Federal medical research institution delivering comprehensive oncology, radiology, and urology care across three branches in Moscow and Obninsk. Core services include advanced radiation and proton therapy, PET/CT diagnostics, bone marrow transplantation, radioembolization, brachytherapy, CAR-T cell therapy, da Vinci robotic surgery, reconstructive surgery, fertility preservation (CryoBank), and a molecular-genetic diagnostic service performing approximately 3.5 million tests per year.

Product overview

National Medical Research Radiological Center (NMRRC) of the Ministry of Health of Russia is a federal oncology and radiology center comprising three branches: the P. Hertsen Moscow Oncology Research Institute (MORI), the A. Tsyb Medical Radiological Research Center (MRRC) in Obninsk, and the N. Lopatkin Scientific Research Institute of Urology and Interventional Radiology. NMRRC offers a comprehensive portfolio of diagnostic and treatment services centered on oncology, radiotherapy, urology, and interventional radiology. The center provides advanced radiation and proton therapy, PET/CT imaging, bone marrow transplantation, radioembolization, brachytherapy, CAR-T cell therapy, da Vinci robotic surgery, fertility preservation (CryoBank), and reconstructive surgery. It also operates molecular-genetic, immunohistochemical, and cytogenetic diagnostic services (~3.5 million tests/year), a molecular-genetic service, telemedicine consultations, reference centers, and cancer screening/check-up programs. The center employs approximately 3,500 staff and serves over 100,000 patients annually.

Differentiator

Problem solved

Functional benefit

Brands

• МНИОИ им. П.А. Герцена (MORI): P. Hertsen Moscow Oncology Research Institute - a branch specializing in oncology surgery, chemotherapy, and diagnostics
• МРНЦ им. А.Ф. Цыба (MRRC)
• НИИ урологии им. Н.А. Лопаткина (Uroline)

Products and services

• Radiation and Proton Therapy (Лучевая и протонная терапия) Advanced radiation and proton therapy technologies for treating malignant tumors, delivered to cancer patients.
• PET/CT Diagnostics (ПЭТ/КТ) Positron emission tomography combined with computed tomography for effective diagnosis of oncological diseases.
• Bone Marrow Transplantation (Трансплантация костного мозга) Treatment of stage 4 tumors of the hematopoietic system through bone marrow and hematopoietic stem cell transplantation.
• Radioembolization (Радиоэмболизация) Treatment of liver tumors using radioembolization with domestically developed microspheres.
• Brachytherapy (Брахитерапия) Brachytherapy for malignant diseases including liver and pancreas treatment using the domestic radioisotope iodine-125.
• Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatment of peritoneal carcinomatosis using pressurized intraperitoneal aerosol chemotherapy.
• Reconstructive and Plastic Surgery (Реконструктивно-пластическая хирургия) Reconstructive and plastic surgery for radiation injuries and breast reconstruction using the patient's own tissues; approximately 2,100 procedures performed annually.
• CAR-T Cell Therapy (CAR-T терапия) CAR-T cell therapy for the treatment of oncohematological diseases, a form of advanced immunotherapy.
• Fertility Preservation / CryoBank (Сохранение фертильности / КриоБанк) Cryopreservation of reproductive cells and tissues to preserve fertility for cancer patients undergoing chemotherapy and radiation; a patented program.
• da Vinci Robotic Surgery (Роботическая хирургия da Vinci) Robotic surgery using the da Vinci system for urological and other surgical procedures.
• Nuclear Medicine (Ядерная медицина) Nuclear medicine services including diagnostic and therapeutic applications of radionuclides.
• Molecular Genetic Service (Молекулярно-генетическая служба) Molecular-genetic, immunohistochemical, and cytogenetic diagnostic services supporting therapy personalization, performing approximately 3.5 million clinical diagnostic tests per year.
• Cancer Screening and Check-up Programs (Программы онкоскрининга и чек-апов) Cancer screening and check-up programs including gender-specific diagnostic packages and comprehensive health assessments.
• Telemedicine Consultations (Телемедицинские консультации) Telemedicine consultation services providing remote expert medical opinions for specialists and patients.
• Reference Center (Референс-центр) Reference center providing verification of morphological and microbiological research results for external specialists.

Quantifiable outcome

• 3.5 million clinical diagnostic tests per year for therapy personalization
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• CIS Countries (Base Oncological Institution)coreStrategic or Co-development PartnerNMITS Radiologii serves as the designated base oncological institution for CIS countries, providing international collaboration, expert opinions, and healthcare coordination across member states.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Gustave Roussy Institute: Leading European comprehensive cancer center in France, combining clinical care, research, and proton therapy. Comparable as a national/European oncology reference center with similar multi-modality, research-driven model.
• European Institute of Oncology (IEO): Milan-based private-academic comprehensive cancer center offering surgery, radiotherapy, and molecular diagnostics with strong international patient flows. Comparable as a multi-modality cancer referral hospital.
• The Royal Marsden NHS Foundation Trust: UK's leading cancer hospital combining NHS-funded oncology care with private patient services and a strong research portfolio. Comparable as a national flagship oncology institution with mixed public/private revenue model.
• MD Anderson Cancer Center: U.S.-based comprehensive cancer center with global leadership in proton therapy, surgical oncology, and precision medicine. Functions as a global benchmark for NMRRC's full-stack oncology offering and research capabilities.
• Memorial Sloan Kettering Cancer Center: U.S. comprehensive cancer hospital integrating surgery, chemotherapy, radiation, and translational research. Comparable as a high-acuity oncology referral institution with deep research capacity and international patient program.

Regional players

• Charité – Universitätsmedizin Berlin: Europe's largest university hospital with significant oncology and radiology service lines. Comparable as a research-intensive multi-specialty academic center, though geographically anchored to Germany.
• Maria Skłodowska-Curie National Research Institute of Oncology: Polish national oncology research and treatment center providing comprehensive oncology services. Comparable as a Central/Eastern European national oncology institute with overlapping scope and similar regional ecosystem.

Direct peers

• National Medical Research Center of Oncology named after N.N. Blokhin: Russia's other flagship federal oncology center under the Ministry of Health, headquartered in Moscow. Provides overlapping comprehensive oncology, surgical, and radiotherapy services at comparable national scale; the most direct functional peer to NMRRC.
• Almazov National Medical Research Centre: Major federal multi-specialty research center in St. Petersburg providing cardiology, oncology, and radiology services with significant scale and academic medical orientation; comparable as a Russian national-level federal clinical-research platform.
• N.N. Petrov National Medical Research Center of Oncology: Leading federal oncology research institute in St. Petersburg under the Ministry of Health. Comparable as a research-driven oncology referral center with surgical oncology, chemotherapy, and radiotherapy capabilities serving a national patient base.

Market position

Strengths1 record

Weaknesses4 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/national-medical-research-radiological-center

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Medical Research Radiological Center